94 related articles for article (PubMed ID: 8012999)
1. Oncogenes, tumour suppressor genes and growth factors in breast cancer: novel targets for diagnosis, prognosis and therapy.
Callahan R; Salomon DS
Cancer Surv; 1993; 18():35-56. PubMed ID: 8012999
[TBL] [Abstract][Full Text] [Related]
2. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer metastasis-associated genes: prognostic significance and therapeutic implications.
Moustafa AS; Nicolson GL
Oncol Res; 1997; 9(10):505-25. PubMed ID: 9507529
[TBL] [Abstract][Full Text] [Related]
4. Oncogenes and growth factors in human lung cancer.
Kern JA; Filderman AE
Clin Chest Med; 1993 Mar; 14(1):31-41. PubMed ID: 8462246
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. [Somatic genetics of breast cancer].
Bièche I; Lidereau R
Bull Cancer; 1997 Jan; 84(1):83-96. PubMed ID: 9180865
[TBL] [Abstract][Full Text] [Related]
7. Implications of the new biology for therapy in breast cancer.
Sledge GW
Semin Oncol; 1996 Feb; 23(1 Suppl 2):76-81. PubMed ID: 8614850
[TBL] [Abstract][Full Text] [Related]
8. Alterations of tumor suppressor genes in bladder cancer.
Cordon-Cardo C; Reuter VE
Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
[TBL] [Abstract][Full Text] [Related]
9. The molecular pathology of human breast cancer.
Walker RA; Varley JM
Cancer Surv; 1993; 16():31-57. PubMed ID: 8348538
[TBL] [Abstract][Full Text] [Related]
10. Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.
Masood S
Surg Oncol Clin N Am; 1995 Oct; 4(4):601-32. PubMed ID: 8535901
[TBL] [Abstract][Full Text] [Related]
11. Linking gene expression patterns to therapeutic groups in breast cancer.
Martin KJ; Kritzman BM; Price LM; Koh B; Kwan CP; Zhang X; Mackay A; O'Hare MJ; Kaelin CM; Mutter GL; Pardee AB; Sager R
Cancer Res; 2000 Apr; 60(8):2232-8. PubMed ID: 10786689
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic pathways in hereditary and sporadic breast cancer.
Kenemans P; Verstraeten RA; Verheijen RH
Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic implications of advances in breast cancer biology].
Bertucci F; Gonçalves A; Maraninchi D
Rev Prat; 2004 Apr; 54(8):865-70. PubMed ID: 15274460
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
Shi M; Guo N
Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
[TBL] [Abstract][Full Text] [Related]
15. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
Sakorafas GH; Tsiotou AG; Tsiotos GG
Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
[TBL] [Abstract][Full Text] [Related]
16. The role of TP53 in breast cancer development.
Eeles RA; Bartkova J; Lane DP; Bartek J
Cancer Surv; 1993; 18():57-75. PubMed ID: 8013000
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic molecular biology in breast cancer].
Andersen TI; Børresen-Dale AL
Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2366-9. PubMed ID: 9691806
[TBL] [Abstract][Full Text] [Related]
18. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
[TBL] [Abstract][Full Text] [Related]
19. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
[TBL] [Abstract][Full Text] [Related]
20. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]